BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Drug Development

  Marinus Pharmaceuticals Presents Additional Responder Analysis Data For Ganaxolone In Focal Onset Seizures At The American Epilepsy Society Annual Meeting

  December 7, 2015

   · 

  4 min read
• Genetown

  Radius Health Announces Conference Call And Webcast On New Data For Investigational Drug RAD1901 To Be Presented At San Antonio Breast Cancer Symposium 2015

  December 7, 2015

   · 

  5 min read
• Voluntis And AstraZeneca PLC To Test Companion Mobile App In Ovarian Cancer Studies With The US National Cancer Institute

  December 7, 2015

   · 

  4 min read
• Pharm Country

  Akari Therapeutics Announces Update From Non-Human Primate Safety Study At International PNH Interest Group 10th Annual Scientific Meeting

  December 7, 2015

   · 

  2 min read
• Pharm Country

  Aptuit LLC Announces 16M$ Investment In Capacity And Capability

  December 7, 2015

   · 

  2 min read
• BioCapital

  PharmaCyte Provides Update On Malignant Ascites And New Colon Cancer Studies

  December 7, 2015

   · 

  5 min read
• Drug Development

  Genentech Release: New Results From CLL11 Study Show Gazyva Provided People With Previously Untreated Chronic Lymphocytic Leukemia A Treatment-Free Period Of Nearly Four Years

  December 7, 2015

   · 

  1 min read
• BioMidwest

  BiOptix To Sponsor Scientific Briefing At Upcoming Antibody Engineering & Therapeutics Conference

  December 7, 2015

   · 

  2 min read
• Drug Development

  Arrowhead Research Corporation’s ARC-520 Leads To Consistent Immune Reactivation In Chimpanzees With Chronic Hepatitis B Infection

  December 7, 2015

   · 

  6 min read
• Policy

  Health Canada Issues Notice Of Compliance For Gilead’s Single Tabletregimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofoviralafenamide) For Treatment Of HIV-1 Infection

  December 7, 2015

   · 

  5 min read